Empagliflozin Changes Urine Supersaturation by Decreasing pH and Increasing Citrate.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 35387874.
- Also identified by DOI 10.1681/ASN.2021111515 and PMC identifier 9161803.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
<b>Clinical Trial registry name and registration number:</b> Empagliflozin and Renal Oxygenation in Healthy Volunteers (EMPA-REIN), NCT03093103.
Medical subject headings
- Diabetes Mellitus, Type 2
- Sodium-Glucose Transporter 2 Inhibitors